RETINAL NEURODEGENERATION IN HUNTINGTON'S DISEASE
Abstract
About the Authors
S. N. SvetozarskiyRussian Federation
S. V. Kopishinskaya
Russian Federation
I. G. Smetankin
Russian Federation
References
1. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage / U. Shirendeb [et al.] // Hum. Mol. Genet. - 2011. - Vol. 20, №7. - P. 1438-1455
2. Epidemiology of Huntington disease in Cyprus: A 20-year retrospective study / C. Demetriou [et al.] // Clin Genet. - 2018. - Vol. 93. - P. 656-664
3. Ghosh, R. Clinical Features of Huntington's Disease / R. Ghosh, S. Tabrizi // Adv. Exp. Med. Biol. - 2018. - Vol. 1049. - P. 1-28
4. The first data on retinal optical coherence tomography parameters in Huntington’s disease / S. Kopishinskaya [et al.] // Eur. J. Neurol. - 2014. - Vol. 21(Suppl 1). - P. 36
5. Optical coherence tomography findings in Huntington’s disease: a potential biomarker of disease progression / H. Kersten [et al.] // J. Neurol. - 2015. - Vol. 262, №11. - P. 2457-2465
6. Patterns of Retinal Ganglion Cell Damage in Neurodegenerative Disorders: Parvocellular vs Magnocellular Degeneration in Optical Coherence Tomography Studies / C. La Morgia [et al.] // Front. Neurol. - 2017. - Vol. 8. - P. 710
7. Retinal single-layer analysis with optical coherence tomography shows inner retinal layer thinning in Huntington’s disease as a potential biomarker / D. Sevim [et al.] // Int. Ophthalmol. - 2019. -Vol. 39, №3. - P. 611-621
8. Spectral-Domain Optical Coherence Tomography as a Potential Biomarker in Huntington's Disease / C. Andrade [et al.] // Mov. Disord. - 2016. - Vol. 31, №3. - P. 377-383
9. Wong-Riley, M. Energy metabolism of the visual system / M. Wong-Riley // Eye Brain. - 2010. - Vol. 2. - P. 99-116
Review
For citations:
Svetozarskiy S.N., Kopishinskaya S.V., Smetankin I.G. RETINAL NEURODEGENERATION IN HUNTINGTON'S DISEASE. Bashkortostan Medical Journal. 2020;15(4):38-40. (In Russ.)